Additionally, MYC is almost ubiquitously expressed at each stage of tumor development; it can be upregulated through direct transcriptional targeting by many other genes, thereby driving proliferation and therapeutic resistance (Hubbard et al., 2016). Here, MYC is linked to neoplasm.